Telesis Bio CLO Robert H. Cutler to depart Oct 31; severance of $307,500 with acceleration clause

Telesis Bio Inc.

CLO Robert H. Cutler departs effective Oct 31, 2024; may enter consulting agreement for transition.
Severance of $307,500 (9 months salary) paid in installments; accelerated if company raises $4M.
Company to pay $23,596.88 for nine months of COBRA premiums.
Cutler signs general release in favor of the company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Robert H. Cutler

Chief Legal Officer

Telesis Bio Inc.

Effective: 2024-10-31
Filed: October 25, 2024, 7:59 PM ET

Telesis Bio Inc. (the "Company") announced that effective October 31, 2024, Robert H. Cutler, the Company's Chief Legal Officer, will depart the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert H. Cutler departed as Chief Legal Officer at Telesis Bio Inc..

Action: will depart
Role: Chief Legal Officer

Exact text from the filing

Telesis Bio Inc. (the "Company") announced that effective October 31, 2024, Robert H. Cutler, the Company's Chief Legal Officer, will depart the Company.

View on SEC.gov

Source: SEC EDGAR

accession 0000950170-24-117462

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.